- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy high growth potential
South Korean Pharmaceuticals & Biotech Healthy high growth potential
Results
5
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
5 companies
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,100.00
7D
-1.8%
1Y
15.6%
HansBiomed
Market Cap: ₩271.8b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩19,060.00
7D
-16.2%
1Y
146.6%
ALTEOGEN
Market Cap: ₩21.1t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩303,500.00
7D
-4.4%
1Y
-6.3%
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩391,000.00
7D
-4.2%
1Y
-40.1%
DreamCIS
Market Cap: ₩81.3b
Operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada.
A223250
₩3,305.00
7D
-5.6%
1Y
-2.4%